RX+
DEAD

Serial Number

90392562

Owner

ASTELLAS PHARMA INC.

Attorney

Christopher Bolinger

Filing Date

Dec 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RX+ Trademark

Serial Number: 90392562 • Registration: 6656643

RX+ is a trademark filed by ASTELLAS PHARMA INC. on December 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ASTELLAS PHARMA INC. (257 trademarks)

3-11 NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

December 18, 2020

Registration Date

March 1, 2022

Published for Opposition

December 14, 2021

Cancellation Date

October 13, 2023

Goods & Services

Instruction in the field of dosage management; entertainment services, namely, providing online computer games; providing therapeutic exercise instruction; sports club services, namely, physical fitness instruction

Downloadable medical software for processing and displaying images on ultrasound medical imaging machines, downloadable computer software for controlling and managing patient medical information, downloadable medical software for processing and displaying affected part images on medical resonance imaging machines (MRIs), downloadable software for medical imaging equipment, namely, for interpreting the results of CT scanners, downloadable computer programs for use in the operation of medical ultrasound detectors, computer software for medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and for conducting medical diagnostic testing

Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct; Reagent paper for medical purposes

Medical service, medical diagnostic testing services, surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct

Medical apparatus for detecting and treating for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and diagnostic imaging

Providing temporary use of on-line non-downloadable computer programs for use in medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct, research and development services in the field of scientific or medical field, providing scientific research information in the field of clinical trials

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 10, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 10, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 10, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 10, 2025 REAP
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Oct 14, 2023 NCS7
CANCELLED SECTION 7-TOTAL
Oct 13, 2023 C7..
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 10, 2023 APRE
REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Feb 28, 2023 C7RF
TEAS SECTION 7 SURRENDER RECEIVED
Feb 28, 2023 ES7S
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 1, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 14, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 5, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 5, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 5, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 5, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2021 CRFA
ASSIGNED TO EXAMINER
Nov 3, 2021 DOCK
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 17, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 17, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 17, 2021 CNRT
ASSIGNED TO LIE
May 12, 2021 ALIE
ASSIGNED TO EXAMINER
May 8, 2021 DOCK
ASSIGNED TO EXAMINER
Apr 30, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 2, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2021 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 2, 2021 PARI
NEW APPLICATION ENTERED
Dec 22, 2020 NWAP